Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab

G. M. Falco; Giacomo Caldarola; A. D'Amore; L. M. Pinto; Clara De Simone; Ketty Peris

doi:10.1002/ski2.371

Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab

G. M. Falco^*, Giacomo Caldarola, A. D'Amore, L. M. Pinto, Clara De Simone, Ketty Peris

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

: Several eczematous eruptions have been described during treatment with anti-IL17A and anti-IL17 receptor drugs. In our case, however, the patient had been treated for 2 years with an IL-17A inhibitor without ever developing eczematous reactions, which occurred, however, shortly after starting therapy with bimekizumab, an IL-17A, F and A/F inhibitor.

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	Skin Health and Disease
Volume	4
Numero di pubblicazione	5
DOI	https://doi.org/10.1002/ski2.371
Stato di pubblicazione	Pubblicato - 2024

All Science Journal Classification (ASJC) codes

Dermatology

Keywords

psoriasis

Accesso al documento

10.1002/ski2.371

Altri file e collegamenti

Cita questo

@article{57ed7ab06aee4487ab26ba6208f82aed,

title = "Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab",

abstract = ": Several eczematous eruptions have been described during treatment with anti-IL17A and anti-IL17 receptor drugs. In our case, however, the patient had been treated for 2 years with an IL-17A inhibitor without ever developing eczematous reactions, which occurred, however, shortly after starting therapy with bimekizumab, an IL-17A, F and A/F inhibitor.",

keywords = "psoriasis, psoriasis",

author = "Falco, {G. M.} and Giacomo Caldarola and A. D'Amore and Pinto, {L. M.} and {De Simone}, Clara and Ketty Peris",

year = "2024",

doi = "10.1002/ski2.371",

language = "English",

volume = "4",

pages = "N/A--N/A",

journal = "Skin Health and Disease",

issn = "2690-442X",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab

AU - Falco, G. M.

AU - Caldarola, Giacomo

AU - D'Amore, A.

AU - Pinto, L. M.

AU - De Simone, Clara

AU - Peris, Ketty

PY - 2024

Y1 - 2024

N2 - : Several eczematous eruptions have been described during treatment with anti-IL17A and anti-IL17 receptor drugs. In our case, however, the patient had been treated for 2 years with an IL-17A inhibitor without ever developing eczematous reactions, which occurred, however, shortly after starting therapy with bimekizumab, an IL-17A, F and A/F inhibitor.

AB - : Several eczematous eruptions have been described during treatment with anti-IL17A and anti-IL17 receptor drugs. In our case, however, the patient had been treated for 2 years with an IL-17A inhibitor without ever developing eczematous reactions, which occurred, however, shortly after starting therapy with bimekizumab, an IL-17A, F and A/F inhibitor.

KW - psoriasis

UR - https://publicatt.unicatt.it/handle/10807/299902

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85202853283&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85202853283&origin=inward

U2 - 10.1002/ski2.371

DO - 10.1002/ski2.371

M3 - Article

SN - 2690-442X

VL - 4

SP - N/A-N/A

JO - Skin Health and Disease

JF - Skin Health and Disease

IS - 5

ER -

Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo